Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

All articles and reminders · November 4, 2026

Published November 4, 2026 · Reporting window October 25–31, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

All articlesSearch this edition →
Compliance Sweep: complete report →Enforcement Briefing: complete report →Medicare & Medicaid Sweep: complete report →

42 articles and reminders, grouped by category.

Compliance Sweep

Higher-priority matters

Patient care & rights 4 articles and reminders

Patient care & rightsCompliance SweepNew in this edition

Medically frail court opinion

On October 29, 2026, the District of Massachusetts concluded that an added limitation requiring impairment of community engagement for certain medically frail determinations was contrary to law. The court rejected the states’ arbitrary-and-capricious challenges to the 12-month claims and encounter-data lookback and limits on self-attestation. The opinion discusses vacatur, a permanent injunction and a six-month enforcement stay for plaintiff states, while its formal order grants and denies the cross-motions in part without specifying those terms. The operative relief, timing, geographic and party scope, and later proceedings remain unverified.

Medium priority · Nov 4, 2026 editionRead story →

Patient care & rightsCompliance SweepNew in this edition

OIG patient-engagement safe-harbor cap

OIG’s annual inflation update, marked October 28, 2026, lists a $646 cap for 2027, up from $623 for 2026. The cap is one condition of the patient-engagement safe harbor and applies to the annual aggregate retail value of tools and supports furnished to a patient by a value-based enterprise participant; other safe-harbor conditions also apply.

Medium priority · Nov 4, 2026 editionRead story →

Patient care & rightsCompliance SweepNew in this edition

FTC healthcare marketing warning template

An FTC warning-letter template concerning marketing, advertising and lead generation for healthcare-related products, including healthcare plans, is labeled “Date Sent” October 29, 2026 on its official landing page. The template says some marketing and lead-generation practices may violate law and discusses potential misrepresentations about coverage, costs or incentives, impersonation and telemarketing; it recommends reviewing relevant practices. It expressly states that the letter is not a conclusion that a recipient engaged in illegal conduct. Organizations involved in health-plan marketing or lead generation can compare their practices with applicable requirements.

Medium priority · Nov 4, 2026 editionRead story →

Patient care & rightsCompliance SweepNew in this edition

California proposes permanent hospice agency regulations

California’s regulatory notice describes a proposal to permanently adopt Title 22 hospice agency requirements addressing licensure, management qualifications, service areas and oversight. Written comments must be received by December 14, 2026; a public hearing is scheduled for December 15, 10 a.m. to noon Pacific. The separate emergency regulations are already in effect; the proposed permanent adoption remains a rulemaking action.

Medium priority · Nov 4, 2026 editionRead story →

Payment & health plan rules 1 articles and reminders

Payment & health plan rulesCompliance SweepNew in this edition

OPO conditions for coverage

CMS’s October 30 fact sheet describes a final rule revising organ procurement organization conditions for coverage, including adverse-event, research-organ record, designation, competition and transition provisions. The rule retains the three-tier recertification framework; an OPO losing a competition to retain a tier 2 donation service area faces nonrenewal of its agreement for designation to that donation service area, not automatic decertification of the entire OPO. Post-window publication update: CMS published CMS-3409-F on November 3, 2026, at 91 FR 69390–69444. The published rule states an effective date of January 4, 2027. Publication does not establish any particular organization’s compliance with the rule.

Medium priority · Nov 4, 2026 editionRead story →

Governance & business operations 10 articles and reminders

Governance & business operationsCompliance SweepNew in this edition

HHS Section 504 public-inspection rule

HHS filed a final rule for public inspection on October 30, 2026, concerning its Section 504 disability regulations for programs and activities receiving HHS financial assistance. The retained text would revise 45 CFR 84.4(g) to state HHS’s interpretation that the statutory exclusion for gender identity disorders not resulting from physical impairments includes gender dysphoria not resulting from physical impairments. Post-window publication update: HHS published the final rule on November 3, 2026, at 91 FR 69207–69223. The published rule states an effective date of January 4, 2027. HHS’s interpretation does not resolve the effect of court orders or other applicable federal and state protections in a particular case.

Medium priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

HHS draft 503A peptide compounding policy

On October 30, HHS announced a draft enforcement-discretion policy concerning certain peptide bulk drug substances used in section 503A compounding while the applicable bulk-substances list is developed. The notice requests written comments within two weeks after publication. HHS says the draft does not establish rights and is not binding on HHS or the public. The notice does not establish blanket permission to compound every peptide; the named substances, conditions and current status require review.

Medium priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

Centanafadine Schedule III interim rule

DEA issued an interim final rule placing centanafadine, including its salts, isomers and salts of isomers where possible, in Schedule III effective October 30, 2026. The rule requests comments by November 30. The rule's actual provisions and applicability should be reviewed for an organization's circumstances; this summary does not assert a particular patient's treatment or a universal prescribing change.

Medium priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

HTI-5 certification criteria

ONC’s HTI-5 final rule, published October 28, 2026, removes 14 and revises seven of the 60 health IT certification criteria it describes as currently in effect, while retaining 39 unchanged. ONC says proposals not addressed in the final rule remain under consideration. Removing a certification criterion does not itself require vendors to remove a feature or erase other applicable obligations. The published rule is effective December 28, 2026, except amendatory instructions 7, 10 and 12, which are effective January 1, 2027.

Medium priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Medline beds and accessories

FDA’s device-safety listing identifies an October 29 early alert concerning Medline-brand beds and associated products. A subsequently viewed FDA alert describes electrical overheating and fire risks as well as separate entrapment or asphyxiation risks associated with accessories, a pendant or loose rails. FDA says all Medline-brand beds and associated components are affected, including home-care, bariatric and long-term-care beds. FDA reports that covered beds, rails, mattresses and accessories may remain in use under the updated instructions until the bed is repaired or replaced. The later-observed precautions include unplugging beds except when needed for repositioning, avoiding extension cords and, whenever possible, having a second person assist with use and movement. FDA advises against repairing, modifying or altering a bed except through the specified Medline-authorized process.

High priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: selected B. Braun Dialog+ bloodlines

FDA’s device-safety listing identifies an October 27 early alert for selected B. Braun Streamline Bloodline Sets for the Dialog+ hemodialysis system. The later-viewed FDA alert identifies model SL-2010M2096 and lots A2600099, A2600128 and A2600136. FDA describes a potentially inadequately bonded dialyzer connector that could detach or leak during priming or dialysis, risking blood loss or interrupted treatment. FDA says to ensure all users are informed and to identify and quarantine affected devices. Its description of B. Braun’s October 20 letter says to inform users, have distributors forward the notice to consignees, determine inventory, stop use, quarantine and return affected product to the manufacturer.

High priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA recall: selected HemosIL HIT assay lots

FDA’s device-safety listing identifies an October 30 confirmed recall of selected lots of HemosIL AcuStar HIT-IgG(PF4-H), used with other information to aid assessment of heparin-induced thrombocytopenia. In the FDA page captured November 2, part 0009800127 is associated with lots B40005 and B38062, and part 0009802028 with lots B40006 and B38063. FDA describes a negative bias of 20–35% that may produce results below the 1.00 U/mL cutoff and be interpreted as HIT IgG antibody negative. The page also contains internally inconsistent error-type wording; its title and device-use description use different assay terminology.

High priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

EEOC criminal-record guidance

The EEOC announced October 29 that the Commission voted October 28 to rescind its 2012 enforcement guidance on the use of arrest and conviction records in employment decisions under Title VII, effective immediately. The agency says Title VII continues to prohibit unlawful discrimination. Healthcare employers should consult employment and licensing counsel about applicable requirements before changing background-check practices. The rescission instrument and state-specific requirements have not been independently reviewed here.

Medium priority · Nov 4, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA clarifies safety steps for StatStrip Gen 2.0 glucose meters

FDA says prior patient or quality-control information can remain on the affected meter screen and, if accepted, assign a glucose result to the wrong record. The agency says users with an alternative meter should stop using the affected meter until it is updated. Where no alternative is available, users should follow the manufacturer’s interim safeguards, including the identification checks described in the FDA communication. FDA reported one serious injury and no deaths as of October 5.

High priority · Nov 4, 2026 editionRead story →

More matters and continuing watch

Patient care & rights 1 articles and reminders

Governance & business operations 1 articles and reminders

Enforcement Briefing

Higher-priority matters

Billing fraud & false claims 1 articles and reminders

Billing fraud & false claimsEnforcement BriefingNew in this edition

DOJ reports California physician sentenced in Medicare Botox billing case

DOJ reports that a California physician received a 15-year sentence after convictions in a Medicare Botox billing scheme. The court ordered restitution and forfeiture, with restitution collection and net recovery not established in the announcement.

High priority · Nov 4, 2026 editionRead story →

Patient safety & protection 2 articles and reminders

Patient safety & protectionEnforcement BriefingNew in this edition

Virginia behavioral-health charges

On October 28, DOJ announced the arrest of a Virginia mental-health provider executive charged in connection with Medicaid crisis-services billing. DOJ alleges more than $49 million in false claims were submitted from January 2022 through April 2026, and describes alleged discrepancies between documented and actual staffing, falsified signatures and inducements. The indictment was returned October 20; the charges are allegations, and the defendant is presumed innocent unless proven guilty.

Medium priority · Nov 4, 2026 editionRead story →

Patient safety & protectionEnforcement BriefingNew in this edition

Three Minnesota Medicaid fraud charging matters

On October 30, DOJ announced charges in three Minnesota Medicaid fraud matters. It reported an October 29 information against Habiba Mohamed in an alleged $19.1 million scheme, and October 28 indictments against Faiza Osman Ahmed involving an alleged $10 million scheme and Jama Yusuf Mohamod involving approximately $3.2 million in allegedly fraudulent claims. Charges are allegations and the defendants are presumed innocent.

Medium priority · Nov 4, 2026 editionRead story →

Consumer & business misconduct 6 articles and reminders

Consumer & business misconductEnforcement BriefingNew in this edition

Hive ransomware sentencing

On October 27, a federal court sentenced Artem Stryzhak to 70 months in prison for his role in Hive ransomware activity, DOJ reported. DOJ attributed roughly 1,500 victims to the wider conspiracy and seven victims to Stryzhak and co-conspirators. DOJ described a hospital disruption in its account of the wider group; it did not identify that hospital as one of the seven.

Medium priority · Nov 4, 2026 editionRead story →

Consumer & business misconductEnforcement BriefingNew in this edition

California hospice enrollment decision

In an October 27, 2026 decision, an HHS administrative law judge affirmed CMS’s authority to revoke Glencare’s Medicare enrollment and place it on the preclusion list, based on the billing findings described in the decision. The contractor’s original notice was issued in August 2024, and the revocation took effect in September 2024. The judge said the length of the ten-year reenrollment bar was outside the judge’s review authority.

Medium priority · Nov 4, 2026 editionRead story →

Consumer & business misconductEnforcement BriefingNew in this edition

Kentucky dialysis communication agreement

On October 27, DOJ announced an ADA settlement following a complaint concerning communication with a deaf patient at a Lexington, Kentucky dialysis facility. DOJ said its investigation substantiated the complaint and that DaVita cooperated. The agreement says DaVita denies the allegations and is not admitting liability. DOJ describes updates to communication policies and practices, staff training and complaint reporting. The agreement describes measures for defined Kentucky facilities and provides for compensation and a civil penalty, subject to its conditions; it does not establish that those amounts have been paid.

Medium priority · Nov 4, 2026 editionRead story →

Consumer & business misconductEnforcement BriefingNew in this edition

DMEPOS enrollment decision

In an October 27, 2026 decision, an HHS administrative law judge affirmed the earlier revocation of Monasak’s DMEPOS enrollment after its insurance and accreditation lapsed. The decision found no evidence that the supplier had submitted a written voluntary termination before it became noncompliant. The earlier notice included a one-year reenrollment bar; the decision does not establish its current status.

Medium priority · Nov 4, 2026 editionRead story →

Consumer & business misconductEnforcement BriefingUpdated

Prior-duty update: Roy and Ramancha proceedings

A DOJ victim-notification page marked updated October 27 reports that Swapnadip Roy’s status conference, previously scheduled for October 13, was continued to December 8, 2026, and his November 2 trial was continued to the January 2027 trial calendar. DOJ does not state when the continuance orders were entered. Roy and Vicky Ramancha face charges in the counterfeit Ozempic case; those charges are allegations and the defendants are presumed innocent.

Medium priority · Nov 4, 2026 editionRead story →

Consumer & business misconductEnforcement BriefingNew in this edition

DOJ reports guilty plea in Medicare COVID test-kit scheme

DOJ reports that Syed Murtuza Kablazada pleaded guilty to two health-care fraud counts involving Medicare claims for COVID-19 test kits that were not requested or provided. DOJ says the laboratories submitted $227 million in claims, of which Medicare paid approximately $136 million. DOJ also says Kablazada agreed to forfeit more than $46 million seized from bank accounts. Claims, payments and agreed forfeiture are distinct amounts; the release does not establish a sentence or completed recovery.

Medium priority · Nov 4, 2026 editionRead story →

Medicare & Medicaid Sweep

Higher-priority matters

Billing & payment 3 articles and reminders

Billing & paymentMedicare & Medicaid SweepNew in this edition

CMS increases the dialysis base rate and changes low-volume, home-training and quality policies for 2027

CMS set the 2027 Medicare dialysis base rate at $297.52 per treatment and revised low-volume, pediatric, home-training and quality policies. Eligible facilities seeking the 2027 low-volume adjustment face a December 31, 2026 attestation date; individual payment effects depend on facility circumstances.

High priority · Nov 4, 2026 editionRead story →

Billing & paymentMedicare & Medicaid SweepNew in this edition

2027 SNF consolidated-billing update

On October 26, 2026, CMS issued Transmittal 14003 (CR 14658) for the 2027 annual skilled nursing facility consolidated-billing update. It states a January 1, 2027 effective date and January 4 implementation date, and directs contractors to use the new A/B MAC (A) and (B) SNF coding files for applicable 2027 dates of service. The transmittal alone does not establish individual code changes or actual file postings.

Medium priority · Nov 4, 2026 editionRead story →

Billing & paymentMedicare & Medicaid SweepUpdated

2027 physician fee-schedule database instructions

On October 26, 2026, CMS issued Transmittal 14026 (CR 14618), rescinding and replacing R13960 and consolidating contractor instructions for the January, April, July and October 2027 Medicare Physician Fee Schedule database releases. Contractors must be prepared to retrieve up to three replacement payment datasets per release if corrections are required. For the April, July and October updates, contractors must give providers 30 days’ notice before implementing changes and adjust claims brought to their attention, without searching files to retract payment or retroactively pay already paid claims. This is not a provider filing deadline and does not establish that any replacement files were issued.

Medium priority · Nov 4, 2026 editionRead story →

Coverage & clinical policy 1 articles and reminders

Provider operations 8 articles and reminders

Provider operationsMedicare & Medicaid SweepNew in this edition

Exchange eligibility verification proposal

HHS and CMS proposed changes to Exchange eligibility verification, annual redeterminations and enrollment timing in a rule published October 27. The executive summary describes circumstances in which an Exchange generally could not authorize advance premium tax credits and cost-sharing reductions for an otherwise eligible applicant while specified eligibility inconsistencies remain unresolved, subject to a stated family-size special-enrollment exception; other inconsistencies are treated differently. Comments must be received by November 27, 2026, for assured consideration. This is a proposal, not a final rule; the full applicability schedule and all exceptions remain to be reviewed.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepNew in this edition

SNF quality refresh and January preview

CMS says its October skilled nursing facility quality-data refresh is available, with older Medicare Spending Per Beneficiary data remaining in place. CMS had already announced the spending-data delay in July. Separately, an October 15 notice identifies November 14 for review of January 2027 preview reports, subject to CMS's review and data-correction rules.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepConditional reminder

Reminder: DMEPOS order and prior-authorization lists

The July 30 notice set October 28, 2026 as the general implementation date for its DMEPOS list updates. It adds 22 specified HCPCS codes to the face-to-face encounter and written-order-before-delivery list and separately adds eight specified codes to the required prior-authorization list. Prior authorization for specified upper-limb orthoses is phased, starting October 28 in California, Florida, Michigan and New York; later phases are January 26 and April 26, 2027. The date’s arrival does not itself establish actual implementation; exact codes, exceptions and later amendments remain open.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepNew in this edition

DHCS behavioral-health state plan proposal

On October 29, 2026, California DHCS issued a revised public notice for proposed Alternative Benefit Plan State Plan Amendment 26-0034. DHCS says the proposal would clarify behavioral health treatment policy, including utilization-management controls, and support program integrity. The revised notice applies only to 26-0034; DHCS says the June 30 notice for Medicaid State Plan Amendment 26-0033 remains unchanged. The notice states a July 1, 2026 proposed effective date subject to CMS approval; it does not establish approval or identify the specific utilization controls.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepConditional reminder

Reminder: Home health QRP reconsideration

CMS’s October 23 entry says noncompliance notices for agencies determined noncompliant with CY 2027 annual payment update reporting requirements were placed in iQIES My Reports on October 23. An agency receiving a noncompliance letter may request reconsideration by 11:59 p.m. November 23, 2026, following its notice and CMS instructions. The cited page passage does not specify a time zone; the actual notice and instructions should be checked. This is a conditional reminder, not an in-week new announcement or a finding against any named agency.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepUpdated

Prior-duty update: California rural health funding

On October 29, CMS said California had committed its full fiscal-year 2026 rural-health funding, more than $233 million, to programs across the state. This updates the same funding story as prior finding GC-2026-0329, which reported a $233,639,308.47 first-budget-period award and $219,133,495 put to work through July 31 based on earlier state-reported obligations. The October announcement should not be added to that award as separate new funding or treated as proof of disbursement to particular providers.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepUpdated

Prior-duty update: Noridian A57079 R7

Noridian’s October 29 Jurisdiction E Part B notice reports an A57079 revision effective November 1, 2026. It says the Group 1 medical-necessity asterisk explanation specifies diagnosis M72.0 for CPT 20527 and 26341. This R7 notice follows the R6 conformity update described in our October 11 finding; the notice does not determine an individual claim’s medical necessity or payment. The current complete article and earlier R6 table were not reviewed here.

Medium priority · Nov 4, 2026 editionRead story →

Provider operationsMedicare & Medicaid SweepUpdated

Prior-duty update: Noridian A60217 R2

Noridian’s October 29 Jurisdiction E notice says revision R2 to billing and coding article A60217 adds 0665U to Group 1 for specified liver-disease biomarker testing, effective October 1, 2026. Noridian cautions that a code’s inclusion does not automatically mean coverage. This is a potential update to the October 11 finding GC-2026-0134; compare the current article and LCD with the earlier version before treating it as a material change. The current complete article, LCD and registry details remain open.

Medium priority · Nov 4, 2026 editionRead story →

More matters and continuing watch

Provider operations 2 articles and reminders

Audits & program integrity 2 articles and reminders

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies